A urethral stricture can seriously impact a man’s life. Previous treatments available had low success rate, but there are new options available to treat the condition. Dr. Jeremy B. Myers talks about ...

The FDA has granted approval to Urotronic Inc. for its Optilume urethral drug-coated balloon (DCB) for the treatment of male urethral strictures. The device inhibits new scar tissue growth that may ...

Urethral strictures refer to the narrowing of the urethra, which is the tube that carries urine out of the body. This condition is typically caused by scarring, which can block or narrow the urethra, ...

Radiation therapy is an essential treatment for prostate cancers. Complications from radiation are very rare, but occasionally men can develop a urethral stricture after radiation treatment. The ...

The Optilume device includes a balloon coated with paclitaxel. The Food and Drug Administration (FDA) has approved the Optilume ® Urethral Drug Coated Balloon (DCB) to treat patients with obstructive ...

Treating male urethral stricture with the patient’s own buccal mucosal cells, encapsulated in a polymer scaffold as carrier, has been granted a patent in Japan. A longer duration of relief to patients ...

NICE commissioned an external assessment centre (EAC) to review the evidence submitted by the company. This section summarises that review. Full details of all the evidence are in the project ...

The committee noted that the clinical evidence showed Optilume to be effective in improving clinically relevant outcomes including anatomical success, peak flow rate and international prostate symptom ...